NEW YORK (AP) -- Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging has hit a rough patch....
Associated Press: Health
Tue, 06/27/2017 - 10:07am
NEW YORK (AP) -- Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging has hit a rough patch....